PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?

The standard of care for newly diagnosed advanced ovarian cancer (NADOC) is represented by surgical debulking followed by systemic platinum–taxanes combination chemotherapy. At the last European Society for Medical Oncology (ESMO) Congress, results from three trials testing three different poly-aden...

Full description

Saved in:
Bibliographic Details
Published in:Front Oncol
Main Authors: Franzese, Elisena, Diana, Anna, Centonze, Sara, Pignata, Sandro, De Vita, Ferdinando, Ciardiello, Fortunato, Orditura, Michele
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7303974/
https://ncbi.nlm.nih.gov/pubmed/32596142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00782
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items